These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 25115050

  • 1. Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not.
    Nwenyi E, Leafman J, Mathieson K, Ezeobah N.
    Int J Health Care Qual Assur; 2014; 27(6):468-81. PubMed ID: 25115050
    [Abstract] [Full Text] [Related]

  • 2. Daily home opioid use in adults with sickle cell disease: The PiSCES project.
    Smith WR, McClish DK, Dahman BA, Levenson JL, Aisiku IP, de A Citero V, Bovbjerg VE, Roberts JD, Penberthy LT, Roseff SD.
    J Opioid Manag; 2015; 11(3):243-53. PubMed ID: 25985809
    [Abstract] [Full Text] [Related]

  • 3. Hydroxyurea for children with sickle cell disease.
    Heeney MM, Ware RE.
    Pediatr Clin North Am; 2008 Apr; 55(2):483-501, x. PubMed ID: 18381097
    [Abstract] [Full Text] [Related]

  • 4. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
    Badawy SM, Thompson AA, Lai JS, Penedo FJ, Rychlik K, Liem RI.
    Health Qual Life Outcomes; 2017 Jul 05; 15(1):136. PubMed ID: 28679417
    [Abstract] [Full Text] [Related]

  • 5. Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria.
    Adeyemo TA, Diaku-Akinwunmi IN, Ojewunmi OO, Bolarinwa AB, Adekile AD.
    Hemoglobin; 2019 May 05; 43(3):188-192. PubMed ID: 31462098
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.
    Creary SE, Gladwin MT, Byrne M, Hildesheim M, Krishnamurti L.
    Pediatr Blood Cancer; 2014 Jun 05; 61(6):1068-73. PubMed ID: 24436121
    [Abstract] [Full Text] [Related]

  • 8. The role of hydroxyurea in the management of sickle cell disease.
    Davies SC, Gilmore A.
    Blood Rev; 2003 Jun 05; 17(2):99-109. PubMed ID: 12642122
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyurea therapy in adult Nigerian sickle cell disease: a monocentric survey on pattern of use, clinical effects and patient's compliance.
    Adewoyin AS, Oghuvwu OS, Awodu OA.
    Afr Health Sci; 2017 Mar 05; 17(1):255-261. PubMed ID: 29026400
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
    Al-Jam'a AH, Al-Dabbous IA.
    Saudi Med J; 2002 Mar 05; 23(3):277-81. PubMed ID: 11938415
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Mar 05; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 14. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
    Nkashama GM, Wakamb GK, Mulangu AM, Nkashama GM, Kupa BK, Numbi OL.
    Pan Afr Med J; 2015 Mar 05; 21():124. PubMed ID: 26327961
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
    Salvia AC, Figueiredo MS, Braga JA, Pereira DF, Brighenti FL, Koga-Ito CY.
    J Oral Pathol Med; 2013 Aug 05; 42(7):570-5. PubMed ID: 23278631
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
    Badawy SM, Thompson AA, Penedo FJ, Lai JS, Rychlik K, Liem RI.
    Eur J Haematol; 2017 Jun 05; 98(6):608-614. PubMed ID: 28306171
    [Abstract] [Full Text] [Related]

  • 18. Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea.
    Thornburg CD, Calatroni A, Panepinto JA.
    J Pediatr Hematol Oncol; 2011 May 05; 33(4):251-4. PubMed ID: 21516020
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.